⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Court Upholds Lara's Endorsement Of Insurer Discrimination, Says Consumer Watchdog
prnewswire.com
MRK
Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
ANVS
SUPN
ABBV
VNDA
JAZZ
ACAD
MRK
Merck Opens BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe
globenewswire.com
MRK
ENT Disorder Treatment Market to Reach US$58 Billion by 2034, Driven by Digital Diagnostics and Minimally Invasive Car
globenewswire.com
GSK
SNY
PFE
AZN
NVS
ABBV
JNJ
MRK
MDT
SN
BSX
TEVA
SUN
Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
businesswire.com
MRK
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy
businesswire.com
MRK
Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates
globenewswire.com
MRK
PFE
AZN
LLY
VKTX
STRT
Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines Expand
globenewswire.com
A
BC
IONS
ALNY
ARWR
TMO
AMGN
DHR
LRCX
MRK
MLSS
Market performance in H2 2026 will be driven by AI, despite geopolitical uncertainty and persistent inflation: Natixis Investment Managers Strategists Survey 2026
prnewswire.com
NVDA
MSFT
GOOG
AMZN
META
AMD
INTC
IBM
AMAT
ASML
SMCI
CRWD
PANW
PLTR
ADBE
CRM
LLY
JNJ
MRK
PFE
XOM
CVX
TSLA
GM
F
GOOGL
Inductive Bio Wins 3rd Consecutive AI Drug Discovery Benchmark
prnewswire.com
INDB
MRK
NVO
AMGN